| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.50T | 1.36T | 1.31T | 1.33T | 1.13T |
| Gross Profit | 530.95B | 493.03B | 456.67B | 450.76B | 418.45B |
| EBITDA | 170.93B | 153.44B | 141.49B | 147.39B | 139.09B |
| Net Income | 19.30B | 55.18B | 52.62B | 75.04B | 92.29B |
Balance Sheet | |||||
| Total Assets | 1.54T | 1.46T | 1.41T | 1.34T | 1.27T |
| Cash, Cash Equivalents and Short-Term Investments | 289.83B | 269.45B | 330.48B | 267.38B | 335.24B |
| Total Debt | 232.46B | 224.71B | 204.78B | 233.28B | 243.15B |
| Total Liabilities | 684.18B | 651.57B | 601.96B | 614.10B | 600.68B |
| Stockholders Equity | 857.20B | 804.75B | 810.99B | 727.35B | 665.63B |
Cash Flow | |||||
| Free Cash Flow | 61.24B | 67.81B | 108.98B | 2.21B | 66.96B |
| Operating Cash Flow | 119.15B | 138.07B | 165.57B | 61.31B | 110.80B |
| Investing Cash Flow | -69.51B | -150.79B | -58.98B | -61.60B | -44.08B |
| Financing Cash Flow | -41.99B | -45.13B | -65.39B | -79.35B | -51.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $158.10B | 7.94 | 91.94% | 0.18% | -18.43% | 242.76% | |
74 Outperform | $166.12B | 31.71 | 916.38% | 1.02% | 28.92% | 55.56% | |
72 Outperform | $5.06B | -8.76 | 5.29% | 3.35% | 4.75% | -64.06% | |
64 Neutral | $23.80B | 14.44 | 116.57% | 1.89% | 3.04% | 9.12% | |
62 Neutral | $19.13B | 8.26 | 1135.29% | 5.09% | 5.09% | -5.05% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $18.55B | 7.04 | 18.21% | ― | 56.58% | 1.94% |